The late Tom O'Dorisio, MD, and Sue O'Dorisio, MD, were leaders in the field of neuroendocrine tumors (NET) research and treatment, establishing an NIH-funded Specialized Program of Research Excellence (SPORE) grant within the UI's Holden Comprehensive Cancer Center in 2015. This was quickly followed by a designation as a Center of Excellence, the first in…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.